1177 fundamentals
An in-depth look to SINO BIOPHARMACEUTICAL operating, investing, and financing activities
1177 free cash flow for H2 23 is 3.58 B HKD. For 2023, 1177 free cash flow was 5.87 B HKD and operating cash flow was 7.31 B HKD.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM